Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid‐19

Background The management of critically ill patients with coronavirus disease 2019 (COVID‐19), caused by a new human virus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is challenging. Recently, there have been several reports with inconsistent results after treatment with convalesce...

Full description

Saved in:

Bibliographic Details
Published in:	Transfusion (Philadelphia, Pa.) Vol. 60; no. 10; pp. 2210 - 2216
Main Authors:	Liu, Miao, Chen, Zhen, Dai, Meng‐Yuan, Yang, Jun‐Hui, Chen, Xiao‐Bing, Chen, Di, You, Hua, Guo, Xin, Leng, Yan, Yu, Li, Zhang, Meng‐Li, Wu, Xian, Yang, Junyu, Gao, Chong, Tenen, Daniel G, Chai, Li, Ai, Fen
Format:	Journal Article
Language:	English
Published:	Hoboken, USA John Wiley & Sons, Inc 01.10.2020 Wiley Subscription Services, Inc
Subjects:	Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Coronaviridae Coronaviruses COVID-19 COVID-19 - therapy Critical Illness Cytokine storm Cytokines Health services Humans IgG antibody Immunization, Passive - methods Immunoglobulin G Immunoglobulin G - immunology Laboratories Mass production Neutralizing Oxygenation Patients Plasma Pneumonia Pneumonia - immunology Pneumonia - virology Respiratory diseases SARS-CoV-2 - pathogenicity Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Transfusion Transfusion Medicine Viral diseases Viruses
ISSN:	0041-1132, 1537-2995, 1537-2995
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!